References
- Protection of Human Subjects. 45 CFR §46, 2005. www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm (Accessed: 20 October 2008 ).
- NIH Revitalization Act of 1993 . 1993 . Publ. No. 103-43
- DHHS, FDA. Investigational New Drug Applications and New Drug Applications. 21 CFR Parts 312 and 314. Federal Register, Volume 63, February 11, 1998, page 6854. AND Guidance for Industry. Collection of Race and Ethnicity Data in Clinical Trials. http://www.fda.gov/cder/guidance/5656fnl.htm (Accessed: 3 November 2008 ).
- Research on Cardiovascular Disease in Women Program Brief. Agency for Healthcare Research and Quality, June 2006. http://www.ahrq.gov/research/womheart.htm (Accessed: 10 October 2008 ).
- Gender disparity seen in medical trials. United Press International article on remarks by Dr. Wendy Tsang at the Canadian Cardiovascular Congress 2008 in Toronto. www.upi.com/Health_News/2008/20/28/Gender_disparity_seen_in_medical_trials/UPI-53701225208817/ (Accessed: 5 November 2008 ).
- United States General Accounting Office. GAO-01-286R. Drugs Withdrawn From Market. January 19, 2001. www.gao.gov/new.items/d01286r.pdf (Accessed: 15 October 2008 ).
- Gear , RW , Miaskowski , C , Gordon , NC , Paul , SM , Heller , PH and Levine , JD . 1996 . Kappa-opioids produce significantly greater analgesia in women than in men . Nat Med , 2 : 1184 – 1185 .
- FDA Approves BiDil Heart Failure Drug for Black Patients. June 23, 2005. http://www.fda.gov/bbs/topics/NEWS/2005/NEW01190.html (Accessed: 30 September 2008 ).
- DHHS, FDA, Center for Drug Evaluation and Research. Cardiovascular and Renal Drugs Advisory Committee transcript, June 15, 2005. www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4145T1.pdf (Accessed: 17 October 2008 ).
- Uhl , K and Marts , S . 2008 . Assessing sex differences: methodological considerations . Expert Rev Clin Pharmacol. , 1 : 585 – 587 .
- Du , W , Gadgeel , SM and Simon , MS . 2006 . Predictors of enrollment in lung cancer clinical trials . Cancer. , 106 : 420 – 425 .
- Stewart , JH , Bertoni , AG , Staten , JL , Levine , EA and Gross , CP . 2007 . Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities . Ann Surg Oncol. , 14 : 3328 – 3334 .
- Wendler , D , Kington , R , Madans , J , Van Wye , G , Christ-Schmidt , H , Pratt , LA , Brawley , OW , Gross , CP and Emanuel , E . 2006 . Are racial and ethnic minorities less willing to participate in health research? . PLoS Med. , 3 : e19
- Fouad , MN , Corbie-Smith , G , Curb , D , Howard , BV , Mouton , C , Simon , M , Talavera , G , Thompson , J , Wang , CY , White , C and Young , R . 2004 . Special populations recruitment for the Women's Health Initiative: successes and limitations . Control Clin Trials. , 25 : 335 – 352 .
- Baylor College of Medicine—Eliminating Disparities in Clinical Trials (EDICT). Major deficiencies in the design and funding of clinical trials: a report to the nation on how human studies are conducted. Findings of the Eliminating Disparities in Clinical Trials Project (EDICT) www.bcm.edu/edict/PDF/EDICT_ Project_White_Paper.pdf (Accessed: 10 October 2008 ).